Your browser doesn't support javascript.
loading
SARS-CoV-2 infected cells present HLA-I peptides from canonical and out-of-frame ORFs
Shira Weingarten-Gabbay; Susan Klaeger; Siranush Sarkizova; Leah R Pearlman; Da-Yuan Chen; Matthew R Bauer; Hannah B Taylor; Hasahn L Conway; Christopher H Tomkins-Tinch; Yaara Finkel; Aharon Nachshon; Matteo Gentili; Keith D Rivera; Derin B Keskin; Charles M Rice; Karl R Clauser; Nir Hacohen; Steven A Carr; Jennifer G Abelin; Mohsan Saeed; Pardis C Sabeti.
Affiliation
  • Shira Weingarten-Gabbay; Broad Institute
  • Susan Klaeger; Broad Institute of MIT and Harvard
  • Siranush Sarkizova; Broad Institute of MIT and Harvard
  • Leah R Pearlman; Broad Institute of MIT and Harvard
  • Da-Yuan Chen; Department of Biochemistry, Boston University School of Medicine
  • Matthew R Bauer; Broad Institute of MIT and Harvard
  • Hannah B Taylor; Broad Institute of MIT and Harvard
  • Hasahn L Conway; Department of Biochemistry, Boston University School of Medicine
  • Christopher H Tomkins-Tinch; Broad Institute of MIT and Harvard
  • Yaara Finkel; Department of Molecular Genetics, Weizmann Institute of Science
  • Aharon Nachshon; Department of Molecular Genetics, Weizmann Institute of Science
  • Matteo Gentili; Broad Institute of MIT and Harvard
  • Keith D Rivera; Broad Institute of MIT and Harvard
  • Derin B Keskin; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute
  • Charles M Rice; Laboratory of Virology and Infectious Disease, The Rockefeller University
  • Karl R Clauser; Broad Institute of MIT and Harvard
  • Nir Hacohen; Broad Institute of MIT and Harvard
  • Steven A Carr; Broad Institute of MIT and Harvard
  • Jennifer G Abelin; Broad Institute of MIT and Harvard
  • Mohsan Saeed; Department of Biochemistry, Boston University School of Medicine
  • Pardis C Sabeti; Broad Institute of MIT and Harvard
Preprint in English | bioRxiv | ID: ppbiorxiv-324145
Journal article
A scientific journal published article is available and is probably based on this preprint. It has been identified through a machine matching algorithm, human confirmation is still pending.
See journal article
ABSTRACT
T cell-mediated immunity may play a critical role in controlling and establishing protective immunity against SARS-CoV-2 infection; yet the repertoire of viral epitopes responsible for T cell response activation remains mostly unknown. Identification of viral peptides presented on class I human leukocyte antigen (HLA-I) can reveal epitopes for recognition by cytotoxic T cells and potential incorporation into vaccines. Here, we report the first HLA-I immunopeptidome of SARS-CoV-2 in two human cell lines at different times post-infection using mass spectrometry. We found HLA-I peptides derived not only from canonical ORFs, but also from internal out-of-frame ORFs in Spike and Nucleoprotein not captured by current vaccines. Proteomics analyses of infected cells revealed that SARS-CoV-2 may interfere with antigen processing and immune signaling pathways. Based on the endogenously processed and presented viral peptides that we identified, we estimate that a pool of 24 peptides would provide one or more peptides for presentation by at least one HLA allele in 99% of the human population. These biological insights and the list of naturally presented SARS-CoV-2 peptides will facilitate data-driven selection of peptides for immune monitoring and vaccine development.
License
cc_no
Full text: Available Collection: Preprints Database: bioRxiv Language: English Year: 2020 Document type: Preprint
Full text: Available Collection: Preprints Database: bioRxiv Language: English Year: 2020 Document type: Preprint
...